Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies
Well-designed and Strategically Managed Access and Affordability Programs can be a Key Differentiator for Pharmaceutical Manufacturers
As a pharmaceutical consulting company, Archbow helps biopharma manufacturers design and build access and affordability strategies that create differentiation in the market. Our approach includes a customized mix of strategic and tactical methods, such as:
- Exploring optimal pharmaceutical patient access and affordability approaches
- Pharmaceutical market landscape assessments, including industry trends, competitive intelligence, analog research, real-world benchmarking, and market research
- Strategic ideation and program solution design
- Operations and technology assessments for pharmaceutical patient support programs
- Pharmaceutical Fair Market Value assessments
- Cost modeling for pharmaceutical programs
- LOE market share loss prevention
- Biosimilar strategies
- RFP management and vendor selection (HUB, Copay, PAP, Non-commercial Dispensing, Clinical Nursing Support)
- Program implementation and quality management
- Data aggregation, reporting, and analytics
- Program Optimization
Learn more about our access and affordability team and the differentiators that matter most to manufacturers, and contact us today for assistance with your strategic and tactical patient and prescriber support needs.
You can also hear our experts speak on 10 Steps to Building an Integrated Pharmaceutical Launch Strategy and 5 Hurdles to Patient Support Program Success and How to Overcome Them.
For additional insights on this topic, you may also enjoy the following case studies:
For additional insights on this topic, you may also enjoy the following blog posts:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Brand Planning Season is Here: Is Patient Access Strategy at the Table?
Build patient access into 2027 brand planning to reduce therapy delays, strengthen launch readiness, and drive sustainable pharmaceutical brand growth.
Thinking Beyond the One-Size-Fits-All Approach: Choosing the Ideal 3PL Partnership
Today’s 3PL landscape offers more specialized distribution solutions than ever before. Learn how manufacturers can evaluate third-party logistics providers, align capabilities to product needs, and make informed 3PL partner decisions for a successful pharmaceutical product launch.
No Patient Left Behind: Mastering Specialty Pharmacy Network Transitions
Specialty Pharmacy (SP) networks are not static. As manufacturers evaluate performance, access, and partner capabilities, network changes may become necessary.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|